Skip to main content
. 2015 Aug 23;2(4):140–152. doi: 10.15586/jkcvhl.2015.40

Figure 2:

Figure 2:

Flow chart of possible future management of RCC patients by using microRNAs. MicroRNAs with diagnostic, prognostic and therapeutic properties along with drug response are indicated. Prognostic miRs should allow the identification of ccRCC patients that need specific therapeutic treatments from those which do not need pharmacological therapy.